Caroline Litchfield
Director Financiero/CFO en IMMUNE DESIGN CORP .
Fortuna: - $ al 30/04/2024
Perfil
Caroline A. Litchfield es Directora Financiera y Directora de Immune Design Corp. y Directora Financiera y Vicepresidenta Ejecutiva de Merck & Co. Forma parte del Consejo de Administración de Immune Design Corp. La Sra. Litchfield trabajó anteriormente como Directora Financiera en Merck Sharp & Dohme Ltd. Se licenció en la Universidad de Leicester.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MERCK & CO., INC.
-.--% | 30/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Caroline Litchfield
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNE DESIGN CORP | Director Financiero/CFO | - |
| MERCK & CO., INC. | Director Financiero/CFO | 01/04/2021 |
Antiguos cargos conocidos de Caroline Litchfield.
| Empresas | Cargo | Fin |
|---|---|---|
| ORGANON & CO. | Director/Miembro de la Junta | 31/05/2021 |
| FULFORD (INDIA) LIMITED | Director/Miembro de la Junta | 30/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director Financiero/CFO | 23/06/2009 |
Formación de Caroline Litchfield.
| University of Leicester | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
- Bolsa de valores
- Insiders
- Caroline Litchfield
